Drugs Made In America Acquisition II Corp. DMII

Rank #2290 · Nasdaq · $0.6B market cap

⚠ Going-concern flag — the auditor (MaloneBailey, LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

25.7

P/E

155.2

P/B

-5566.70

ROE

-3587.3%

Op. Margin

–%

Debt Ratio

-218%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E 155.2x, P/B -5566.70x. Ranks in the top 79% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -3587.3%. Ranks in the top 100% of the universe.

Safety ★★★★★

Excellent

Debt ratio -218%. Ranks in the top 5% of the universe. Under 100% is generally considered a safe level.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2025	–	$-0.0B	$0.0B	$-0.0B	–	-218

← See the full screener